Ditte H.
- Country
- Denmark
- Department
- Department of kidney diseases
Research Overview
- Phase III Randomized Double‑Blind Placebo‑Controlled Trial of Elecoglipron (AZD5004) on Renal Decline and Mortality in Adults with Chronic Kidney Disease
- Efficacy and Safety of Finerenone in Non-Diabetic Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
- Evaluation of Dapagliflozin Propanediol on Echocardiographic Cardiac Structure and Function in Chronic Kidney Disease: A 6-Month Randomized Double-Blind Study
Data & Insights
Has run more than one trial at 79 of 415 partner sites.
Specializations
Kidney Disease Management
The investigator specializes in researching therapeutic approaches for chronic kidney disease (CKD), with particular focus on both diabetic and non-diabetic variants. Their work explores innovative treatments using compounds like finerenone and dapagliflozin to address disease progression.
- Non-diabetic CKD interventions
- Standard of care optimization
- Disease progression markers
Cardiac-Renal Connections
The investigator conducts research examining the relationship between cardiac structure and kidney function. Their work includes evaluation of cardiac structural changes and function across various stages of CKD using advanced echocardiographic measures.
- Cardiac structural assessment
- Systolic function evaluation
- Diastolic parameters
Specialized Kidney Conditions
The investigator focuses on specific kidney disorders including IgA Nephropathy and adynamic bone disorder. Their research extends to investigating targeted therapies such as atacicept and teriparatide for these conditions.
- Proteinuria management
- Bone metabolism in CKD
- Novel therapeutic applications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.